IPOL

NDC 50090-1693 · A-S Medication Solutions

Generic namePOLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED), POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED), and POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED)

Dosage formINJECTION, SUSPENSION

RouteINTRAMUSCULAR

Active ingredient(s)POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED), POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED), POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED)

Strength40; 8; 32 [D'ag'U]/.5mL; [D'ag'U]/.5mL; [D'ag'U]/.5mL

Pharmacologic classActively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Inactivated Poliovirus Vaccine [EPC], Inactivated Poliovirus Vaccine [EPC], Inactivated Poliovirus Vaccine [EPC], Poliovirus Vaccines [CS], Poliovirus Vaccines [CS], Poliovirus Vaccines [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS]

Marketing categoryBLA

Packages

50090-1693-9 — 1 VIAL, MULTI-DOSE in 1 PACKAGE (50090-1693-9) / 5 mL in 1 VIAL, MULTI-DOSE (50090-1693-0)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

49281-564 — diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine, 49281-860 — POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED), POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED), and POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED), 50090-7541 — Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined, 58160-811 — Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined, 58160-812 — Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine, 63083-4003 — Virus Nosode, 63083-4023 — Low Virus Nosode, 63083-6033 — Travel Immunization Detox, 63083-9409 — Childhood Vaccination Nosode Combination, 63361-243 — diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, haemophilus b conjugate and hepatitis b vaccine

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.